Pooled Clinical Trial Analysis of Tiotropium Safety
- 1 December 2006
- Vol. 130 (6) , 1695-1703
- https://doi.org/10.1378/chest.130.6.1695
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Improvements in Symptom-Limited Exercise Performance Over 8 h With Once-Daily Tiotropium in Patients With COPDChest, 2005
- COX-2 Inhibitors — Lessons in Drug SafetyNew England Journal of Medicine, 2005
- Improvement in Exercise Tolerance With the Combination of Tiotropium and Pulmonary Rehabilitation in Patients With COPDChest, 2005
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEuropean Respiratory Journal, 2004
- Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary diseaseThorax, 2003
- Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax, 2003
- Hospitalizations and Mortality in the Lung Health StudyAmerican Journal of Respiratory and Critical Care Medicine, 2002
- A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2002
- Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung diseaseLife Sciences, 1999
- Review papers : The statistical basis of meta-analysisStatistical Methods in Medical Research, 1993